Literature DB >> 18242542

Markers of inflammation before and after curative ablation of atrial flutter.

Gregory M Marcus1, Lisa M Smith, David V Glidden, Emily Wilson, Jamie M McCabe, Dean Whiteman, Zian H Tseng, Nitish Badhwar, Byron K Lee, Randall J Lee, Melvin M Scheinman, Jeffrey E Olgin.   

Abstract

BACKGROUND: Atrial arrhythmias are associated with inflammation. The cause and effect of the association are unknown.
OBJECTIVE: The purpose of this study was to test the hypothesis that atrial tachyarrhythmias contribute to inflammation.
METHODS: We performed a prospective observational study wherein C-reactive protein (CRP) and interleukin-6 (IL-6) levels from the femoral vein and coronary sinus (CS) were compared before curative ablation for atrial flutter (AFL; n = 59) and paroxysmal supraventricular tachycardia (SVT; n = 110). Follow-up levels were obtained at 1 and 6 months.
RESULTS: Peripheral levels of both biomarkers were significantly higher in the AFL group. After multivariate adjustment, only those in the AFL group who presented in AFL or atrial fibrillation (AF) had significantly elevated CRP levels (odds ratio 1.26; P = .033). Levels of each marker were similar in the CS and peripheral blood in the SVT group; in the AFL group, both CRP and IL-6 were significantly lower in the CS than in the periphery (P = .0076 and P = .0021, respectively). CRP was significantly lower a median of 47 days after AFL ablation (from a median of 6.28 mg/L to a median of 2.92 mg/L; P = .028) and remained reduced at second follow-up. IL-6 decreased across three time points after AFL ablation (P = .002). No reduction in inflammatory biomarkers was observed after SVT ablation.
CONCLUSIONS: CRP and IL-6 levels are elevated in patients presenting in AFL. Given the lower CS values in these patients, their origin appears to be systemic rather than cardiac. Because these levels significantly fall after ablation of AFL, the atrial tachyarrhythmia appears to be the cause (not the effect) of the inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18242542      PMCID: PMC2247371          DOI: 10.1016/j.hrthm.2007.10.007

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  23 in total

Review 1.  Catheter ablation of supraventricular arrhythmias: state of the art.

Authors:  Fred Morady
Journal:  J Cardiovasc Electrophysiol       Date:  2004-01

Review 2.  Results of radiofrequency catheter ablation for atrial flutter.

Authors:  L A Saxon; J M Kalman; J E Olgin; M M Scheinman; R J Lee; M D Lesh
Journal:  Am J Cardiol       Date:  1996-05-01       Impact factor: 2.778

3.  Long-term outcome of radiofrequency catheter ablation for typical atrial flutter: risk prediction of recurrent arrhythmias.

Authors:  C T Tai; S A Chen; C E Chiang; S H Lee; Z C Wen; J L Huang; Y J Chen; W C Yu; A N Feng; Y J Lin; Y A Ding; M S Chang
Journal:  J Cardiovasc Electrophysiol       Date:  1998-02

4.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; José Luis Zamorano
Journal:  J Am Coll Cardiol       Date:  2006-08-15       Impact factor: 24.094

5.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation.

Authors:  A Frustaci; C Chimenti; F Bellocci; E Morgante; M A Russo; A Maseri
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

6.  Simultaneous multisite mapping studies during induced atrial fibrillation in the sterile pericarditis model. Insights into the mechanism of its maintenance.

Authors:  K Kumagai; C Khrestian; A L Waldo
Journal:  Circulation       Date:  1997-01-21       Impact factor: 29.690

7.  Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia.

Authors:  P Bruins; H te Velthuis; A P Yazdanbakhsh; P G Jansen; F W van Hardevelt; E M de Beaumont; C R Wildevuur; L Eijsman; A Trouwborst; C E Hack
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

8.  Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation.

Authors:  Dwayne S g Conway; Peter Buggins; Elizabeth Hughes; Gregory Y H Lip
Journal:  Am Heart J       Date:  2004-09       Impact factor: 4.749

9.  Catheter ablation of atrial flutter using radiofrequency energy.

Authors:  H Calkins; A R Leon; A G Deam; S J Kalbfleisch; J J Langberg; F Morady
Journal:  Am J Cardiol       Date:  1994-02-15       Impact factor: 2.778

10.  Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.

Authors:  R L Page; W E Wilkinson; W K Clair; E A McCarthy; E L Pritchett
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

View more
  20 in total

1.  The importance of the mean platelet volume in the diagnosis of supraventricular tachycardia.

Authors:  Tarik Ocak; Alim Erdem; Arif Duran; Ümit Yaşar Tekelioğlu; Serkan Öztürk; Suzi Selim Ayhan; Mehmet Fatih Özlü; Mehmet Yazici
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

Review 2.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

Review 3.  Inflammation and the pathogenesis of atrial fibrillation.

Authors:  Yu-Feng Hu; Yi-Jen Chen; Yenn-Jiang Lin; Shih-Ann Chen
Journal:  Nat Rev Cardiol       Date:  2015-01-27       Impact factor: 32.419

4.  IntravenousCorticosteroid Use Is Associated With Reduced Early Recurrence of Atrial Fibrillation Immediately Following Radiofrequency Catheter Ablation.

Authors:  Nitesh A Sood; Guru M Krishnan; Craig I Coleman; Jeffrey Kluger; Moise Anglade; Christopher A Clyne
Journal:  J Atr Fibrillation       Date:  2011-09-30

5.  Intracardiac and extracardiac markers of inflammation during atrial fibrillation.

Authors:  Gregory M Marcus; Lisa M Smith; Karen Ordovas; Melvin M Scheinman; Albert M Kim; Nitish Badhwar; Randall J Lee; Zian H Tseng; Byron K Lee; Jeffrey E Olgin
Journal:  Heart Rhythm       Date:  2009-10-12       Impact factor: 6.343

6.  The importance of the mean platelet volume in the diagnosis of supraventricular tachycardia.

Authors:  T Ocak; A Erdem; A Duran; U Tekelioglu; S Öztürk; S Ayhan; F M Özlü; M Yazici
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

7.  Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: the National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project.

Authors:  Renate B Schnabel; Kathleen F Kerr; Steven A Lubitz; Ermeg L Alkylbekova; Gregory M Marcus; Moritz F Sinner; Jared W Magnani; Philip A Wolf; Rajat Deo; Donald M Lloyd-Jones; Kathryn L Lunetta; Reena Mehra; Daniel Levy; Ervin R Fox; Dan E Arking; Thomas H Mosley; Martina Müller-Nurasyid; Taylor R Young; H-Erich Wichmann; Sudha Seshadri; Deborah N Farlow; Jerome I Rotter; Elsayed Z Soliman; Nicole L Glazer; James G Wilson; Monique M B Breteler; Nona Sotoodehnia; Christopher Newton-Cheh; Stefan Kääb; Patrick T Ellinor; Alvaro Alonso; Emelia J Benjamin; Susan R Heckbert
Journal:  Circ Cardiovasc Genet       Date:  2011-08-16

8.  Targeted sequencing in candidate genes for atrial fibrillation: the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Targeted Sequencing Study.

Authors:  Honghuang Lin; Moritz F Sinner; Jennifer A Brody; Dan E Arking; Kathryn L Lunetta; Michiel Rienstra; Steven A Lubitz; Jared W Magnani; Nona Sotoodehnia; Barbara McKnight; David D McManus; Eric Boerwinkle; Bruce M Psaty; Jerome I Rotter; Joshua C Bis; Richard A Gibbs; Donna Muzny; Christie L Kovar; Alanna C Morrison; Mayetri Gupta; Aaron R Folsom; Stefan Kääb; Susan R Heckbert; Alvaro Alonso; Patrick T Ellinor; Emelia J Benjamin
Journal:  Heart Rhythm       Date:  2013-11-14       Impact factor: 6.343

9.  Atrial fibrillation is associated with hematopoietic tissue activation and arterial inflammation.

Authors:  Philip Joseph; Amorina Ishai; Megan MacNabb; Amr Abdelbaky; Zachary R Lavender; Jeremy Ruskin; Matthias Nahrendorf; Ahmed Tawakol
Journal:  Int J Cardiovasc Imaging       Date:  2015-09-28       Impact factor: 2.357

10.  Protracted CRP elevation after atrial fibrillation ablation.

Authors:  James M McCabe; Lisa M Smith; Zian H Tseng; Nitish Badhwar; Byron K Lee; Randall J Lee; Melvin M Scheinman; Jeffrey E Olgin; Gregory M Marcus
Journal:  Pacing Clin Electrophysiol       Date:  2008-09       Impact factor: 1.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.